| Celecoxib 200 mg bid | Diclofenac SR 75 mg bid Plus Omeprazole 20 mg qd | |
|---|---|---|
| Total n=2238 |
Total n=2246 |
|
| Age, Years, n (%) | ||
| <55 | 176 (7.9) | 164 (7.3) |
| 55-59 | 122 (5.5) | 113 (5.0) |
| 60-64 | 721 (32.2) | 742 (33.0) |
| 65-69 | 623 (27.8) | 618 (27.5) |
| 70-74 | 361 (16.1) | 390 (17.4) |
| ≥75 | 235 (10.5) | 219 (9.8) |
| Mean (SD) | 65.2 (7.8) | 65.3 (7.6) |
| Range | 26-89 | 25-93 |
| Sex, n (%) | ||
| Male | 390 (17.4) | 424 (18.9) |
| Female | 1848 (82.6) | 1822 (81.1) |
| Race, n (%) | ||
| White | 1238 (55.3) | 1212 (54.0) |
| Black | 49 (2.2) | 57 (2.5) |
| Asian | 299 (13.4) | 311 (13.8) |
| Hispanic | 462 (20.6) | 464 (20.7) |
| Other | 190 (8.5) | 202 (9.0) |
| Weight (kg), n (%) | 2231 (99.7) | 2242 (99.8) |
| Mean (SD) | 72.5 (15.2) | 72.9 (14.8) |
| Range | 37.5-186.0 | 37.9-150.0 |
| Height (cm), n (%) | 2232 (99.7) | 2242 (99.8) |
| Mean (SD) | 159.1 (9.3) | 159.7 (9.4) |
| Range | 130.0-199.0 | 130.0-192.0 |
| Primary Diagnosis, n (%) | ||
| OA | 1884 (84.2) | 1890 (84.1) |
| RA | 354 (15.8) | 356 (15.9) |
| Patients with Any Concomitant Medications, n (%) a | ||
| Total patients | 1871 (84.2) | 1913 (85.5) |
| Most Frequently (>5%) Used | ||
| Amlodipine | 127 (5.7) | 153 (6.8) |
| Atenolol | 110 (4.9) | 128 (5.7) |
| Calcium carbonate | 117 (5.3) | 119 (5.3) |
| Enalapril | 232 (10.4) | 222 (9.9) |
| Hydrochlorothiazide | 198 (8.9) | 199 (8.9) |
| Methotrexate | 187 (8.4) | 197 (8.8) |
| Paracetamol | 395 (17.8) | 395 (17.7) |
| Medical History (Occurring in >2% Patients), n (%) | ||
| Gastroduodenal ulceration | 395 (17.6) | 400 (17.8) |
| Peptic ulcer | 44 (2.0) | 51 (2.3) |
| Gastric ulcer | 133 (5.9) | 150 (6.7) |
| Duodenal ulcer | 228 (10.2) | 212 (9.4) |
| Gastritis | 347 (15.5) | 362 (16.1) |
| Hemorrhoids | 177 (7.9) | 142 (6.3) |
| Anemia | 49 (2.2) | 52 (2.3) |